Iga nephropathy (igan) Clinical Trials
Conditions / Iga nephropathy (igan)
Delta Trials tracks 25 clinical trials for Iga nephropathy (igan) in its publicly accessible dataset. Among the listed trials, 13 open for participant enrollment and 2 trials have reached completion. This research is carried out at 62 clinical sites around the world. An additional 10 trials have active registrations outside the recruiting and completed categories. Since 2020, 1 trial have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
25
Total Trials
13
Recruiting
2
Completed
10
Other Active
1
Terminated since 2020
62
Study Locations
Browse by location (62 total)
- Beijing, China 6 trialsAll trials in Beijing, China
- Shanghai, China 3 trialsAll trials in Shanghai, China
- Hangzhou, China 2 trialsAll trials in Hangzhou, China
- Chengdu, China 2 trialsAll trials in Chengdu, China
- Nanjing, China 2 trialsAll trials in Nanjing, China
- Brisbane, United States 2 trialsAll trials in Brisbane, United States
- Cheonan, South Korea 1 trialAll trials in Cheonan, South Korea
- Yinchuan, China 1 trialAll trials in Yinchuan, China
- Xi’an, China 1 trialAll trials in Xi’an, China
- Perugia, Italy 1 trialAll trials in Perugia, Italy
- Dakota Dunes, United States 1 trialAll trials in Dakota Dunes, United States
- Córdoba, Spain 1 trialAll trials in Córdoba, Spain
- Córdoba, Spain 1 trialAll trials in Córdoba, Spain
- Gyeonggi-do, South Korea 1 trialAll trials in Gyeonggi-do, South Korea
- Woolloongabba, Australia 1 trialAll trials in Woolloongabba, Australia
- Shatin, Hong Kong 1 trialAll trials in Shatin, Hong Kong
- Moscow, Russia 1 trialAll trials in Moscow, Russia
- Columbus, United States 1 trialAll trials in Columbus, United States
- Leicester, United Kingdom 1 trialAll trials in Leicester, United Kingdom
- Taichung, Taiwan 1 trialAll trials in Taichung, Taiwan